[Systemic therapy of metastatic renal cell carcinoma: from many options to the therapeutic strategy].

Ringhoffer, M

[Systemic therapy of metastatic renal cell carcinoma: from many options to the therapeutic strategy]. [electronic resource] - Der Urologe. Ausg. A Nov 2009 - 1308-17 p. digital

Publication Type: Journal Article; Review

1433-0563

10.1007/s00120-009-2109-y doi


Algorithms
Antibodies, Monoclonal--therapeutic use
Antineoplastic Agents--adverse effects
Carcinoma, Renal Cell--drug therapy
Disease Progression
Humans
Interferon-alpha--adverse effects
Interleukin-2--adverse effects
Intracellular Signaling Peptides and Proteins--antagonists & inhibitors
Neoplasm Staging
Practice Guidelines as Topic
Protein Serine-Threonine Kinases--antagonists & inhibitors
Protein-Tyrosine Kinases--antagonists & inhibitors
TOR Serine-Threonine Kinases